Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Podcasts

TARGET
Podcast and Video
TARGET Study Confirms the Significance of Tumor Absorbed Dose of Tumor Response and Overall Survival
06/05/2021
TARGET is a global real-world study set across eight countries that confirms TheraSphere as safe and effective treatment for HCC, demonstrating reproducible clinical outcomes across a broad patient population. Professor Marnix Lam and Dr....
TARGET is a global real-world study set across eight countries that confirms TheraSphere as safe and effective treatment for HCC, demonstrating reproducible clinical outcomes across a broad patient population. Professor Marnix Lam and Dr....
TARGET is a global real-world...
06/05/2021
IO Learning
Dr Jason Levy
Podcasts
Twelve-Month Outcomes From the OPuS-One Study: A Conversation With Dr Jason Levy
05/25/2021
This episode of IOL Radio features Dr Jason Levy, lead investigator of the OPuS One trial, which studied the quality of life outcomes from a global, prospective, non-randomized, multicenter study of RFA using Medtronic’s OsteoCool system for...
This episode of IOL Radio features Dr Jason Levy, lead investigator of the OPuS One trial, which studied the quality of life outcomes from a global, prospective, non-randomized, multicenter study of RFA using Medtronic’s OsteoCool system for...
This episode of IOL Radio...
05/25/2021
IO Learning
Dr Joseph J. Busch and Kathy Busch
Podcasts
Integrating the TULSA System Into a Dedicated Prostate Cancer Treatment Facility
02/23/2021
Our guests today are from the Busch Center, a clinic in Alpharetta, Georgia that is dedicated to the screening, diagnosis, and treatment of prostate cancer. Dr Joseph J. Busch, Junior, is the clinic’s Oncological Radiologist, and has over 40...
Our guests today are from the Busch Center, a clinic in Alpharetta, Georgia that is dedicated to the screening, diagnosis, and treatment of prostate cancer. Dr Joseph J. Busch, Junior, is the clinic’s Oncological Radiologist, and has over 40...
Our guests today are from the...
02/23/2021
IO Learning

Advertisement

LEGACY
Podcasts
The LEGACY Study Confirms TheraSphere™ as a Neoadjuvant or Standalone Therapy in Treating HCC
12/10/2020
In this episode of IOL Radio, we discuss the results of the LEGACY Study, a robust multicenter study confirming Boston Scientific’s TheraSphere™ as a neoadjuvant or standalone therapy in treating hepatocellular carcinoma.
In this episode of IOL Radio, we discuss the results of the LEGACY Study, a robust multicenter study confirming Boston Scientific’s TheraSphere™ as a neoadjuvant or standalone therapy in treating hepatocellular carcinoma.
In this episode of IOL Radio, we...
12/10/2020
IO Learning
Dr Jason Levy
Podcasts
The OPuS One Study: Advancing Clinical Evidence in the Treatment of Bone Metastases
12/07/2020
The OsteoCool™ RF Ablation System is a cooled radiofrequency ablation technology that offers simultaneous dual-probe capabilities for treating painful bone tumors. Dr Jason Levy joins us to discuss outcomes on the first 100 patients treated...
The OsteoCool™ RF Ablation System is a cooled radiofrequency ablation technology that offers simultaneous dual-probe capabilities for treating painful bone tumors. Dr Jason Levy joins us to discuss outcomes on the first 100 patients treated...
The OsteoCool™ RF Ablation...
12/07/2020
IO Learning
Podcasts
NuView Life Science`s VPAC1 Technology: An Interview With Dr Albert DeNittis
11/30/2020
In this episode of IOL Radio, we speak with Dr Albert DeNittis, a radiation oncologist at Lankenau Cancer Center in Wynnewood, Pennsylvania. Dr Dennitis is here to discuss NuView Life Science’s VPAC1, a peptide platform that detects the...
In this episode of IOL Radio, we speak with Dr Albert DeNittis, a radiation oncologist at Lankenau Cancer Center in Wynnewood, Pennsylvania. Dr Dennitis is here to discuss NuView Life Science’s VPAC1, a peptide platform that detects the...
In this episode of IOL Radio, we...
11/30/2020
IO Learning

Advertisement
Podcasts
CIOctober 2020 Highlights With Dr Ripal Gandhi
09/27/2020
Dr Ripal Gandhi, course director for the Symposium on Clinical Interventional Oncology (CIO), discusses the upcoming virtual meeting, "CIO October."
Dr Ripal Gandhi, course director for the Symposium on Clinical Interventional Oncology (CIO), discusses the upcoming virtual meeting, "CIO October."
Dr Ripal Gandhi, course director...
09/27/2020
IO Learning
Intra-Arterial Chemotherapy for Retinoblastoma with Dr Eric Monroe and Dr Christopher Beck
Podcasts
Intra-Arterial Chemotherapy for Retinoblastoma with Dr Eric Monroe and Dr Christopher Beck
08/19/2020
Backtable Podcast Episode #81:Interventional Radiologist Dr Eric Monroe from Seattle Children's walks us through Intra-Arterial Chemotherapy (IAC) for treatment of Retinoblastoma. In certain patients with retinoblastoma, IAC is a safe and...
Backtable Podcast Episode #81:Interventional Radiologist Dr Eric Monroe from Seattle Children's walks us through Intra-Arterial Chemotherapy (IAC) for treatment of Retinoblastoma. In certain patients with retinoblastoma, IAC is a safe and...
Backtable Podcast Episode...
08/19/2020
IO Learning

Subscribe

IO Learning Newsletter

News

News
Novel Endovascular Robotic Surgical System Reaches Midpoint of Pivotal Clinical Trial
09/20/2024
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY®...
09/20/2024
IO Learning
News
Histotripsy Demonstrates Technical Success, Safety for Primary and Metastatic Liver Tumors
09/04/2024
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the...
09/04/2024
IO Learning
News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use